Obesity

The disease of obesity often brings cardiometabolic consequences, including hypertension, which remains the most potent and predictive risk factor for cardiovascular disease.

Hormonal dysregulation seen in polycystic ovary syndrome can cause a cascade of issues for women, from hirsutism and weight gain to subfertility and type 2 diabetes. Yet beyond the reproductive years, the condition is often ignored.

Women with polycystic ovary syndrome and high androgen levels may have a higher risk for liver disease than those with PCOS and normal androgen levels, according to an analysis of UK Biobank data.

Patients with end-stage kidney disease may be at higher risk for hypoglycemia, with a disproportionate effect on young, Black and female patients, according to published data.

New prescriptions of GLP-1 receptor agonists for the treatment of obesity have increased significantly among individuals without type 2 diabetes in the last decade, according to a study in Annals of Internal Medicine.

In a single-center cohort of patients with heart failure and obesity, weight-loss surgery led to improved clinical outcomes including reduced BMI and HbA1c and less reliance on diuretics, researchers reported.

The American Heart Association’s PREVENT equations predicted that people with stage 1 hypertension have a lower 10-year risk for atherosclerotic CVD compared with the Pooled Cohort Equations.

Researchers have identified two loci that may be associated to AKI in hospitalized patients with kidney disease, noting a potential genetic risk of the condition, data show.

CHICAGO — There is no harm in adding wild blueberries to a weight-loss regimen — in fact, they may even help to curb food cravings and preserve lean body mass, according to results of a small, randomized study presented at NUTRITION.